A multi-center, randomized, double-blind, placebo-contro

  • Kim, Suck W (PI)
  • Grant, Jon (Prior Principal Investigator)

Project: Research project

Project Details


A multi-center, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of low-dose ondansetron for adjuncative therapy in adult patients with obsessive-compulsive disorder who have not adequately responded
Effective start/end date11/15/106/30/14


  • Transcept Pharmaceuticals, Inc.


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.